How we treat data.
Consent, provenance, minimization, oversight and auditability are the operating rules of our platform.
No clinical data enters our infrastructure without explicit, informed and revocable consent through institutional partners.
We track the origin of every data element and collect only what is required for the defined clinical or research purpose.
Every signal returned from the platform is reviewed by qualified clinicians. The platform supports clinical judgment; it does not replace it.
Access controls, encryption, logging and periodic third-party audit are baseline requirements.
Aligned with LGPD (Brazil), HIPAA (US) and international clinical data governance standards.
Let's connect.
If you are exploring international opportunities for a rare disease therapy, clinical program, data initiative or strategic partnership, we would welcome the opportunity to connect.